Cargando…
Liraglutide and the management of overweight and obesity in people with severe mental illness: qualitative sub-study
BACKGROUND: People with severe mental illness are two to three times more likely to be overweight or have obesity than the general population and this is associated with significant morbidity and premature mortality. Liraglutide 3 mg is a once daily injectable GLP-1 receptor agonist that is licensed...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740474/ https://www.ncbi.nlm.nih.gov/pubmed/34996406 http://dx.doi.org/10.1186/s12888-021-03666-5 |